The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.

High-volume centres achieve excellent long-term survival and low reoperation rates in mitral valve repair—key findings ...

Objective: This study aims to investigate the drainage effect and clinical outcomes of negative pressure chest drainage in patients after two-port thoracoscopic valve surgery, comparing the ...

Corewell Health was awarded the Mitral Valve Repair Reference Center Award, one of only 24 centers in the country.

Once you have made the decision to have heart valve replacement surgery, you, along with your surgeon, will need to decide what type of replacement valve is best for you. There are several types of ...

Within a cohort of >600 000 individuals without prior mitral valve intervention, 5.9%–6.8% and 1.6%–1.7% of men and women, had moderate and severe MR. Like severe MR, at the time of investigation, ...

Disney's Q1 2025 EPS of $1.76 beat forecasts by 21.4%, with revenue matching expectations at $24.7 billion Strong growth in Direct-to-Consumer segment and successful box office releases drove ...

EPSS is the one of famous vulnerability score developed by FIRST (the Forum of Incident Response and Security Teams). EPSS's definition: The Exploit Prediction Scoring System (EPSS) is an open, ...

As the number of procedures is expected to rise, a consistent methodology to characterize the mitral valve and identify the most suitable TMVR device for each patient is of paramount importance.